The company, now based in North Beach, has lost more than $2 billion over 29 years. Its only approved drug, called roxadustat ...
H.C. Wainwright analyst Matthew Keller keeps a Buy rating on FibroGen (FGEN) with a $10 price target after the company announced the sale of ...
Tokyo Gas has acquired a 20% stake in FGEN LNG, the owner and operator of an offshore floating liquefied natural gas (LNG) ...
FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its ...
Purchase price represents enterprise value of $85 million plus FibroGen net cash held in China at closing, currently estimated to be ...
FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...
Tokyo Gas said on Wednesday it had made its first foray into a commercially operational terminal for liquefied natural gas ...
The Philippines received 17 cargoes in 2024. Currently it has two receiving terminals – alongside Batangas, Philippines LNG, ...
Lopez-led First Gen Corp. has completed the sale of a 20-percent stake in its offshore liquefied natural gas terminal in ...
But when multiple insiders are buying like... SAN FRANCISCO, Dec. 16, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of David DeLucia to Chief Financial ...
Japan's largest natural gas utility Tokyo Gas Co. Ltd (Tokyo Gas) has completed its acquisition of a stake in Lopez-led First ...
But when multiple insiders are buying like... FibroGen ( NASDAQ:FGEN ) Third Quarter 2024 Results Key Financial Results Revenue: US$46.3m (up 15% from 3Q 2023). Net... FibroGen Inc (FGEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback